Public Health Trace republishes official recall, outbreak, and surveillance data from CDC, FDA, USDA,
WHO, and other public sources. It is an independent information service, not a medical provider, and
not a substitute for professional medical advice or your local public health department's own guidance.
Policy version 2026-07-21, effective July 21, 2026.
If you are experiencing a medical emergency, call your local emergency services immediately. For food
recalls and disease investigations, always refer to the official CDC, FDA, USDA, WHO, or your local
public health authority for the most current information.
Every FDA drug enforcement recall Public Health Trace has on record, republished from
openFDA's official drug enforcement database. See Health
Alerts for current, active recalls alongside outbreaks and advisories.
Drug recall information is sourced from the FDA's structured openFDA Enforcement
Reports. Newly announced recalls may appear on FDA.gov before they become available in
the structured dataset. See Methodology for how Public
Health Trace imports and refreshes this data.
Labeling: Label Mixup: PROPRANOLOL HCL ER, Capsule, 60 mg may have potentially been mislabeled as the following drug: CINACALCET HCL, Tablet, 30 mg, NDC 55513007330, Pedigree: AD52778_82, EXP: 5/21/2014.
Recall initiated
July 2, 2013
Reported by FDA
January 29, 2014
Distribution
Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Labeling: Label Mixup: GABAPENTIN, Tablet, 600 mg may have potentially been mislabeled as the following drug: ARIPiprazole, Tablet, 15 mg, NDC 59148000913, Pedigree: AD21965_1, EXP: 5/1/2014.
Recall initiated
July 2, 2013
Reported by FDA
January 29, 2014
Distribution
Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Labeling: Label Mixup: CILOSTAZOL, Tablet, 100 mg may have potentially been mislabeled as the following drug: TRIAMTERENE/ HYDROCHLOROTHIAZIDE, Tablet, 37.5 mg/25 mg, NDC 00591042401, Pedigree: W002900, EXP: 6/10/2014.
Recall initiated
July 2, 2013
Reported by FDA
January 29, 2014
Distribution
Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Labeling: Label Mixup: FOSINOPRIL SODIUM, Tablet, 10 mg may have potentially been mislabeled as the following drug: MERCapsuleTOPURINE, Tablet, 50 mg, NDC 00054458111, Pedigree: AD54549_1, EXP: 5/20/2014.
Recall initiated
July 2, 2013
Reported by FDA
January 29, 2014
Distribution
Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
ASPIRIN DR EC, Tablet, 81 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00182106105.
by Aidapak Services, LLC
Reason
Labeling: Label Mixup: ASPIRIN DR EC, Tablet, 81 mg may have potentially been mislabeled as one of the following drugs: SOTALOL HCL, Tablet, 120 mg, NDC 00093106001, Pedigree: AD49448_20, EXP: 5/17/2014; FOLIC ACID, Tablet, 1 mg, NDC 65162036110, Pedigree: W003097, EXP: 6/13/2014.
Recall initiated
July 2, 2013
Reported by FDA
January 29, 2014
Distribution
Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Labeling: Label Mixup: DOXYCYCLINE HYCLATE, Capsule, 100 mg may have potentially been mislabeled as the following drug: RALOXIFENE HCL, Tablet, 60 mg, NDC 00002416530, Pedigree: W002644, EXP: 6/5/2014.
Recall initiated
July 2, 2013
Reported by FDA
January 29, 2014
Distribution
Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Labeling: Label Mixup: METHOCARBAMOL, Tablet, 500 mg may have potentially been mislabeled as the following drug: LOSARTAN POTASSIUM, Tablet, 25 mg, NDC 00093736498, Pedigree: AD46312_16, EXP: 5/16/2014.
Recall initiated
July 2, 2013
Reported by FDA
January 29, 2014
Distribution
Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Labeling: Label Mixup: CapsuleTOPRIL, Tablet, 25 mg may have potentially been mislabeled as the following drug: DULoxetine HCl DR, Capsule, 20 mg, NDC 00002323560, Pedigree AD54587_4, EXP: 5/21/2014.
Recall initiated
July 2, 2013
Reported by FDA
January 29, 2014
Distribution
Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Labeling: Label Mixup: CapsuleTOPRIL, Tablet, 6.25 mg (1/2 of 12.5 mg) may have potentially been mislabeled as the following drug:, LUBIPROSTONE, Capsule, 24 mcg, NDC 64764024060, Pedigree: AD46312_1, EXP: 5/16/2014.
Recall initiated
July 2, 2013
Reported by FDA
January 29, 2014
Distribution
Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Labeling: Label Mixup: FENOFIBRATE, Tablet, 54 mg may have potentially been mislabeled as the following drug: FAMCICLOVIR, Tablet, 500 mg, NDC 00093811956, Pedigree: AD49448_4, EXP: 5/17/2014.
Recall initiated
July 2, 2013
Reported by FDA
January 29, 2014
Distribution
Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Labeling: Label Mixup: TERBUTALINE SULFATE, Tablet, 2.5 mg may have potentially been mislabeled as the following drug: SOTALOL HCL, Tablet, 80 mg, NDC 00093106101, Pedigree: AD52778_85, EXP: 5/21/2014.
Recall initiated
July 2, 2013
Reported by FDA
January 29, 2014
Distribution
Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Labeling: Label Mixup: ACYCLOVIR, Tablet, 800 mg may have potentially been mislabeled as the following drug: PANTOPRAZOLE SODIUM DR, Tablet, 20 mg, NDC 64679043304, Pedigree: AD70690_4, EXP: 5/29/2014.
Recall initiated
July 2, 2013
Reported by FDA
January 29, 2014
Distribution
Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace
does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice --
always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take.
Read the full medical disclaimer.
